In contrast to Ozempic, berberine does not slow down GI motility
With a 2.5mg/mL concentration, that same dose requires 96 units
Average weight reduction reached 20.7 percent after 72 weeks at the 7.2 mg dose, compared to the 14.9 percent seen with 2.4 mg in STEP 1
A study has analyzed how plasma DPP-4 activity and levels of soluble DPP-4 correlate with inflammatory markers (C-reactive protein [CRP], IL-6, TNF-, and monocyte chemoattractant protein-1 [MCP-1]) in a subset of patients with T2DM treated with sitagliptin for 12 months as part of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS, 26)
For this reason, Ozempic and Rybelsus have begun to be prescribed off-label, which has resulted in many people experiencing harmful side effects
The semaglutide component follows the same dose escalation schedule as standard compounded semaglutide: Weeks 1-4: 0.25 mg semaglutide (0.1 mL) Weeks 5-8: 0.5 mg semaglutide (0.2 mL) Weeks 9-12: 1.0 mg semaglutide (0.4 mL) Weeks 13-16: 1.7 mg semaglutide (0.68 mL) Week 17+: 2.4 mg semaglutide (0.96 mL) The niacinamide dose scales proportionally with the injection volume
